Compare BNTX & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | DECK |
|---|---|---|
| Founded | 2008 | 1973 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 12.4B |
| IPO Year | 2019 | 1996 |
| Metric | BNTX | DECK |
|---|---|---|
| Price | $92.14 | $90.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 23 |
| Target Price | ★ $133.46 | $122.45 |
| AVG Volume (30 Days) | 883.2K | ★ 2.3M |
| Earning Date | 05-05-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.90 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $5,472,296,000.00 |
| Revenue This Year | N/A | $11.16 |
| Revenue Next Year | $3.37 | $6.96 |
| P/E Ratio | ★ N/A | $99.03 |
| Revenue Growth | N/A | ★ 9.76 |
| 52 Week Low | $79.81 | $78.91 |
| 52 Week High | $124.00 | $125.45 |
| Indicator | BNTX | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 34.14 |
| Support Level | $89.04 | $78.91 |
| Resistance Level | $94.18 | $105.61 |
| Average True Range (ATR) | 2.59 | 2.70 |
| MACD | 0.02 | -0.65 |
| Stochastic Oscillator | 57.49 | 6.91 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.